Pediatric Speech Therapy Session Frequency and Speech Outcomes

NCT ID: NCT05900180

Last Updated: 2025-05-04

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Clinical Phase

NA

Total Enrollment

39 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-01-01

Study Completion Date

2027-12-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this clinical trial is to compare speech therapy outcomes in children ages 18 months to 16 years who participate in weekly speech therapy with home programming versus every-other week speech therapy with home programming in outpatient speech therapy. The main question it aims to answer is: Does a change in how often speech therapy sessions are delivered show an increased benefit in language and articulation standardized test scores? Participants will be randomly assigned to either (1) weekly or (2) every-other-week speech therapy for a total of 8 sessions. Researchers will compare these two groups to see if there are differences in speech outcomes.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Speech Therapy Language Disorders in Children Articulation Disorders in Children Communication Disorder, Childhood Pediatric Mode of Therapy Frequency of Therapy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Every-other-week therapy with home programming

Receipt of standard speech therapy care (every-other-week) for 8.0 sessions

Group Type ACTIVE_COMPARATOR

Speech Therapy

Intervention Type BEHAVIORAL

Delivery of speech therapy services

Weekly therapy with home programming

Receipt of speech therapy care (every week) for 8.0 sessions

Group Type EXPERIMENTAL

Speech Therapy

Intervention Type BEHAVIORAL

Delivery of speech therapy services

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Speech Therapy

Delivery of speech therapy services

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Medical order for speech therapy
* Patients eligible for speech therapy at Connecticut Children's (qualify for receptive, expressive language and/or articulation therapy)
* Diagnosis of communication disorder.ICD-10 codes will be utilized pertaining to expressive, receptive language and articulation disorders (ICD-10 code specific to patient: F80.0, F80.1, F80.2, F80.4, F80.9, R47.89, R41.841)
* Patient recommended for individual (i.e. not group) treatment
* 18 months to 16 years of age
* Completed 1 plan of care (POC) with a duration of 8 sessions
* Attended at least 80% of scheduled visits during their plan of care period (still completing 8 sessions of therapy, may have extended time to completion).
* Services for a full 8-session plan of care.

Exclusion Criteria

* \- Seeking speech therapy care for treatment of disorders related to diagnosis of voice, feeding, fluency, and/or cognition
* Patient unable to complete standardized tests (EOWPVT-4, ROWPVT-4, GFTA-3, REEL-4)
* Patients in group speech therapy
* Patients younger than 18 months or older than 16 years of age
* Not willing to complete a full POC (8 sessions)
* Unable/unwilling to attend 80% of scheduled visits
Minimum Eligible Age

18 Months

Maximum Eligible Age

16 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Connecticut Children's Medical Center

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Virginia Van Epps, M.Ed.

Role: PRINCIPAL_INVESTIGATOR

Connecticut Children's Medical Center

Mary Dortenzio, MS

Role: STUDY_DIRECTOR

Connecticut Children's Medical Center

Jodi Urzua, MS

Role: STUDY_DIRECTOR

Connecticut Children's Medical Center

Emma Mendillo, MA

Role: STUDY_DIRECTOR

Connecticut Children's Medical Center

Morgan Daur-Schierholz, MS

Role: STUDY_DIRECTOR

Connecticut Children's Medical Center

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Connecticut Children's Medical Center

Hartford, Connecticut, United States

Site Status

Countries

Review the countries where the study has at least one active or historical site.

United States

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

22-160

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Spacing Lidcombe Program Clinic Visits
NCT00680303 UNKNOWN PHASE2
Addressing Treatment Nonresponders
NCT05921227 NOT_YET_RECRUITING PHASE2